US Stock MarketDetailed Quotes
VRPX Virpax Pharmaceuticals
- 0.6990
- +0.0848+13.81%
Close Nov 18 16:00 ET
5.65MMarket Cap-96P/E (TTM)
0.7200High0.6172Low220.66KVolume0.6900Open0.6142Pre Close148.01KTurnover2.83%Turnover RatioLossP/E (Static)8.09MShares5.480052wk High-2.75P/B5.44MFloat Cap0.362552wk Low--Dividend TTM7.79MShs Float360.0000Historical High--Div YieldTTM16.74%Amplitude0.3620Historical Low0.6700Avg Price1Lot Size
About Virpax Pharmaceuticals Company
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
Company Profile
SymbolVRPX
Company NameVirpax Pharmaceuticals
Listing DateFeb 17, 2021
Issue Price10.00
Founded2017
CEOMr. Jatinder Dhaliwal
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address1055 Westlakes Drive,Suite 300
CityBerwyn
ProvincePennsylvania
CountryUnited States of America
Zip Code19312
Phone1-610-727-4597
Websitehttp://www.virpaxpharma.com
Company Executives
- Name
- Position
- Salary
- Jatinder Dhaliwal
- Director and Chief Executive Officer
- --
- Dr. Sheila A. Mathias, J.D.,M.B.A.,PhD
- Chief Scientific Officer
- 498.00K
- Katharyn Field
- Director, Vice President and Principal Executive Officer
- --
- Judy Su
- Director
- --
- Gary Herman
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
